ConferenceSeries Ltd invites all the participants from all over the world to attend 6^th Global Ophthalmologists Annual Meeting during May 16-18 2016 in Osaka, Japan which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Ophthalmology Surgery:

There are a variety of conditions that may call for eye surgery; from cosmetic changes to vision-saving procedures. Each treatment comes with its own benefits, risks, and indications for use. From corrective treatments to orbital implants, today’s advancements can tackle almost any condition and provide a successful solution.

Related Conferences:

International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conference June 16-18, 2016 Alicante, Spain;9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA,Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland 

Ophthalmology Practise:

As the world becomes more complex and knowledge in every field becomes more extensive and detailed, it’s increasingly difficult to master everything in any one area. This is certainly true in the field of ophthalmology, which is undoubtedly one of the reasons for the recent trend towards specialization. However, this is only one of many factors contributing to the shift. Today, the multitude of pressures affecting ophthalmologists in general—and comprehensive ophthalmologists in particular has become so oppressive that many doctors wonder whether comprehensive ophthalmology can survive.

Related Conferences:

International Conference and Expo on Cataract and Refractive Surgery  August 04-05, 2016 Manchester, UK; 7th European Ophthalmology Conference June 16-18, 2016 Alicante, Spain;9th World Ophthalmic Conference Oct 27-28, 2016 Istanbul, Turkey;10th International Conference on Clinical & Experimental Ophthalmology Nov 28-30, 2016 Dubai, UAE;6th Global Ophthalmologists Annual Meeting May 16-18, 2016 Osaka, Japan; 8th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; 2nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA,Future World Ophthalmology Congress of the International Council of Ophthalmology 5–9 February 2016 Guadalajara, Mexico; 8th Ocular Diseases Drug Discovery Conference 21–22 March 2016 San Diego, United States; ARVO 2016 Annual Meeting 1–5 May 2016 Seattle, United States; XII International Congress of the Middle East Africa Council of Ophthalmology (MEACO) 4–8 May 2016 Manama, Bahrain; Medical Ethics and Legal Medicine Alaskan Cruise 3–10 September 2016 Seattle, United States; ESVO Meeting 2015 Lisbon 1–4 October 2015 Lisboa, Portugal; Adaptive Optics and Wave front Control in Microscopy and Ophthalmology 5–7 October 2015 Paris, France; European Association for Vision and Eye Research 2015 Nice 7–10 October 2015 Nice, France; Endocannabinoid Pharmacology Meeting – 2015 29–30 October 2015 Bern, Switzerland 

Retina and Retinal Disorders:

The retina is a thin layer of tissue on the inside back wall of your eye. It contains millions of light-sensitive cells and other nerve cells that receive and organize visual information. Your retina sends this information to your brain through your optic nerve, enabling you to see. Retinal degenerative disorders such as Age-related macular degeneration and myopic macular degeneration affecting young and old from many cultures, races and ethnicities. The central area of the retina contains a high density of colour-sensitive photoreceptor cells called cones which are responsible for color vision and hence any defect and alteration in the central area of the retina will lead to Color vision defects.  On the other hand diseases like Diabetic retinopathy and Retinal tumors can also be responsible for the permanent vision loss if it is not treated on time. Historically, retinal disease has had a low priority in prevention of blindness programs in developing countries. There are several reasons for this. Firstly, it was thought that retinal disease was an uncommon cause of blindness in the developing world; secondly, that the results of treating retinal disease did not justify the effort and expense involved; and, thirdly, that the equipment required was too costly and unreliable for use in a developing country environment. Finally, there is a lack of skilled personnel with sub-specialty training in retinal disease. John Hopkins School of Medicine, UCSF School of Medicine, David Geffen School of Medicine and Mayo Medical School are the leading institute’s associates with ophthalmology.

Related Conferences:
8^th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester; UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2^nd International Conference on Eye and Vision  September 26-28, 2016  Miami, USA;  International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy; 9^th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10^th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16^th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12^th annual World Ophthalmology Roundtable on Leadership Development (WORLD)  November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016  Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting  February 27- March 03, 2016 AZ,USA.
 

Glaucoma: Visual Field Loss

Glaucoma is a multifactorial optic neuropathy that affects more than 50 million people and is the second leading cause of blindness worldwide. The role of intra ocular pressure (IOP) has been well documented as a major modifiable risk factor for glaucoma. Additionally, many glaucoma patients have a relatively low IOP, while some healthy individuals have a relatively high IOP. The disorders can be roughly divided into two main categories, open-angle glaucoma and closed-angle glaucoma. Impaired ocular blood flow regulation in open angle glaucoma as a risk of glaucoma has also been well established, especially over the past two decades. Pathophysiology of glaucoma indicates towards the increased in intraocular pressure which compresses and damages the optic nerve. Once the optic nerve is damaged, it fails to carry visual information to the brain and this result in loss of vision. The exact pathophysiology of glaucoma contributing to this is yet to be determined. Biomarkers for glaucoma have predictive use that could help and guide more specific therapy in some glaucoma patients. Endothelin in glaucoma treatment play a very key role in pathogenesis of glaucoma. Glaucoma accounts for over 10 million visits to physicians each year. In terms of Social Security benefits, lost income tax revenues, and health care expenditures, the cost to the U.S. government is estimated to be over $1.5 billion annually. The Glaucoma Research Society of Canada is the only Canadian non-profit organization solely dedicated to funding glaucoma research. Since 1989, it has raised more than two million dollars in support of 150 research projects. The Society funds 10 to 15% of all independent glaucoma research in Canada. Bascom Palmer and Wills Eye are the top researcher organization for glaucoma.

Related Conferences:
8^th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2^nd International Conference on Eye and Vision September 26-28, 2016  Miami, USA; International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy ; 9^th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10^th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; ICO’s 12^th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016  Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting February 27-March 03 2016 AZ,USA; 16^th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE
 

Neuro-Ophthalmology:

Neuro-ophthalmology is the incorporation of neurology and ophthalmology, often dealing with complex systemic diseases that have manifestations in the visual system. Cerebral Visual Impairment (CVI) includes all visual dysfunctions caused by damage to, or malfunctioning of, the retrochiasmatic visual pathways in the absence of damage to the anterior visual pathways or any major ocular disease. Myasthenia gravis is caused by a breakdown in the normal communication between nerves and muscles which leads to double vision, drooping eyelids and other muscles weakness which effecting the both i.e. neuromuscular activity and also vision. On the other hand nystagmus which is involuntary eye movement acquired in infancy or later in life that may result in reduced or limited vision. Factors like cerebral macular degeneration and chronic progressive external ophthalmoplegia also the major effecting part of neuro-ophthalmology. Diagnostic tools in neuro-ophthalmology are used to investigate and to treat the various condition of neuro-ophthalmology as  Neonatal ocular examination are primarily performed to monitor the presence and progression of Retinopathy of Prematurity. University of Pennsylvania is currently working on neuro-ophthalmology project.

Related Conferences:
8^th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2^nd International Conference on Eye and Vision September 26-28, 2016  Miami, USA; International Conference & Expo on Optometry and Vision Science October 27-29, 2016  Rome, Italy; 9^th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10^th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; First Canadian Glaucoma Meeting  April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting February 27-March 03 2016 AZ, USA; 16^th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12^th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada, USA
 

Lens Disorders and Refractive Surgery:

A cataract is a clouding of the lens in the eye leading to a decrease in vision. They may affect one or both eyes. Often they develop slowly. Symptoms may include faded colors, blurry vision, halos around light, trouble with bright lights, and trouble seeing at night. This may result in trouble driving, reading, or recognizing faces. Poor vision may also result in an increased risk of falling and depression. Cataracts are the cause of half of blindness and 33% of visual impairment worldwide. Cataracts are most commonly due to aging, but may also occur due to trauma, radiation exposure, be present from birth, or occur following eye surgery for other problems. Risk factors include diabetes, smoking tobacco, prolonged exposure to sunlight, and alcohol. Either clumps of protein or yellow-brown pigment may be deposited in the lens reducing the transmission of light to the retina at the back of the eye. Diagnosis is by an eye exam. A cataract is a clouding of the lens in the eye leading to a decrease in vision. They may affect one or both eyes. Often they develop slowly. Symptoms may include faded colors, blurry vision, halos around light, trouble with bright lights, and trouble seeing at night. This may result in trouble driving, reading, or recognizing faces. Poor vision may also result in an increased risk of falling and depression. Cataracts are the cause of half of blindness and 33% of visual impairment worldwide. Cataracts are most commonly due to aging, but may also occur due to trauma, radiation exposure, be present from birth, or occur following eye surgery for other problems. Risk factors include diabetes, smoking tobacco, prolonged exposure to sunlight, and alcohol. Either clumps of protein or yellow-brown pigment may be deposited in the lens reducing the transmission of light to the retina at the back of the eye. Diagnosis is by an eye exam.

Related Conferences:
8^th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2^nd International Conference on Eye and Vision September 26-28, 2016  Miami, USA;  International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy; 9^th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10^th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting Febuary27-March 03, 2016 AZ, USA; 16^th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12^th Annual World Ophthalmology Roundtable on Leadership Development (WORLD)  November 14, 2015 Nevada, USA
 

Ocular Microbiology and Immunology:

Many of the viruses, bacteria, parasites, and fungi that can invade the human body are also capable of attacking the surface or interior of the eye. The natural tendency for immunologic disease to affect the eye derives from a number of factors such as Antibody-dependent & antibody-mediated diseases, Uveitis, intraocular inflammation and cell-mediated diseases. The immune system plays a critical role during transplantation and as the corneal transplantation has become increasingly common since the 1960s and over 40,000 transplants were performed in 1990 in the United States and Canada. The 5-year failure rate for corneal grafts is approximately 35%; corneal graft rejection is the most common cause of graft failure in the late postoperative period but with the recent development in immunotherapy can be a breakthrough to overcome from all the limitations of the conventional procedures. The microbiological infection such as fungal endophthalmitis can affect the vitreous and anterior chamber of the eye and hence the uses of antibiotic in ocular infections have been increased to overcome these conditions. The consumables, equipment and technology markets in the microbiology industry totaled nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.

Related Conferences:
8^th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2^nd International Conference on Eye and Vision  September 26-28, 2016 Miami, USA; International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy; 9^th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10^th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16^th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12^th annual World Ophthalmology Roundtable on Leadership Development (WORLD)  November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting Feburary 27-March 03 2016 AZ, USA
 

Research Trends in Surgical and Medical Ophthalmology:

Translational Ophthalmology is a latest trend that bridges the gap by achieving breakthrough discoveries to patients faster than ever. Translational Research is a new initiative of the National Institutes of Health (NIH) which aims to translate basic research into more advanced form to yield the better results. The research trend discoveries maximize the opportunities to investigate the issues very minutely to decrease the risk of failure especially during surgical procedure like cataract and refractive surgery. Many fruitful facts have been discovered which indirectly helps in treating the respective conditions such as Age-Related Eye Disease Study (AREDS) proved that nutritional supplements (nutrition and ophthalmology) could minimize the risk of AMD. The American Health Assistance Foundation, dedicated to eradicating age-related degenerative diseases, estimates that up to 11 million people in the United States have some form of AMD - a number expected to double by 2050. Estimates of the global cost of visual impairment AMD causes are $343 billion, including $255 billion in direct health care costs, according to the foundation. Ophthalmology represents 18 percent of the average case volume in surgery centers, second behind GI/endoscopy (25 percent). The average surgery center performs 4,869 cases annually, which would average to around 876 ophthalmology cases annually, according to VMG Health's 2009 Intellimarker.

Related Conferences:
8^th Global Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2^nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference & Expo on Optometry and Vision Science October 27-29, 2016 Rome, Italy; 9^th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10^th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16^th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12^th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting February 27-March 03 2016 AZ,USA
 

Ophthalmic Research on Drug Development:

Advances in ophthalmic drug delivery systems such as Punctal Plugs, Ocular Therapeutix, Mati therapeutics (QLT) and gel-forming drops can be breakthrough in ophthalmic research and advance drug delivery system to maximize the therapeutic effect of a particular drug. Topical combination of corticosteroid & anti-infective agents, Drugs used in the treatment of allergic conjunctivitis, Oral & topical nonsteroidal anti-inflammatory agents (NSAIDs) and Retinoblastoma chemotherapy are few developed formulation to treat ophthalmic diseases. Companies like Allergan, Pfizer, Bausch + Lomb, Merck & Co. and Regeneron are actively participated in ophthalmic research and drug development. According to visiongain (Ophthalmic Drugs: World Market Prospects - 2013-2023; October 2013), the worldwide ophthalmic market was $17.5 billion in 2011 and is expected to grow to $34.7 billion by 2023, representing a 5.9% compounded annual growth rate.

Related Conferences:
8^thGlobal Ophthalmology Meeting July 18-20, 2016 Chicago, USA; International Conference and Expo on Cataract & Refractive Surgery August 04-06, 2016 Manchester, UK; World Ophthalmology Conference September 15-17, 2016 Berlin Germany; 2^nd International Conference on Eye and Vision September 26-28, 2016 Miami, USA; International Conference & Expo on Optometry and Vision Science  October 27-29, 2016  Rome, Italy; 9^th World Ophthalmic Conference October 24-26, 2016 Istanbul, Turkey; 10^th International Conference on Clinical & Experimental Ophthalmology November 28-30, 2016 Dubai, UAE; Global Ophthalmology and Glaucoma Conference November 07-09, 2016 Melbourne, Australia; 16^th Emirates Society of Ophthalmology Congress December 10-12, 2015 Dubai, UAE; ICO’s 12^th Annual World Ophthalmology Roundtable on Leadership Development (WORLD) November 14, 2015 Nevada, USA; First Canadian Glaucoma Meeting April 24-26, 2015 Niagara-on-the-lake, Ontario, Canada; Retina 2016 January 18-22, 2016 Hilton Waikoloa Village on Hawaii's Big Island; NANOS Annual Meeting February 27-March 03 2016 AZ, USA
 

Ophthalmology Instruments:

An understanding of the commonly used ophthalmic instruments is essential for any practising ophthalmologists. Ophthalmic instruments according to procedures: